Nkọwapụta Ụlọ ọrụ
Beijing Succeeder Technology Inc. (nke a na-akpọ SUCCEEDER ugbu a), dị na Life Science Park na Beijing China, nke e hiwere na 2003, SUCCEEDER bụ ọkachamara na ngwaahịa nchọpụta thrombosis na hemostasis maka ahịa ụwa.
Dịka otu n'ime ụdị ndị isi na ahịa nchọpụta Thrombosis na Hemostasis nke China, SUCCEEDER enweela ndị otu nyocha na mmepe, mmepụta, ahịa, ahịa na ọrụ, na-enye ndị na-enyocha coagulation na reagents, ndị na-enyocha ọbara, ndị na-enyocha ESR na HCT, ndị na-enyocha nchịkọta platelet, yana ISO 13485, Asambodo CE, na FDA edepụtara.
Nnyocha na D
Dịka otu n'ime ụdị ndị isi na ahịa nchọpụta Thrombosis na Hemostasis nke China, SUCCEEDER enweela ndị otu nyocha na mmepe, mmepụta, ahịa, ahịa na ọrụ, na-enye ndị na-enyocha coagulation na reagents, ndị na-enyocha ọbara, ndị na-enyocha ESR na HCT, ndị na-enyocha nchịkọta platelet, yana ISO 13485, Asambodo CE, na FDA edepụtara.
Kemgbe e guzobere ya na 2003, Succeeder etinyela aka na nnyocha na mmepe, mmepụta na ire ngwa nnwale, ihe ndị e ji eme ihe na ihe oriri n'ọhịa nke nchọpụta thrombosis na hemostasis in vitro, na-enye ụlọ ọgwụ ngwa nnwale akpaaka maka coagulation ọbara, rheology ọbara, hematocrit, nchịkọta platelet, ihe ndị na-akwado reagents na ihe oriri. Succeeder ow bụ ụlọ ọrụ na-emepụta ihe na China kachasị elu n'ọhịa nke nchọpụta in vitro nke thrombosis na hemostasis.
E mepụtala teknụzụ isi nke Succeeder nke gụnyere ngwa ọrụ, ihe ndị e ji eme ihe na ihe oriri, yana ikike nchọpụta na mmepe teknụzụ pụrụ iche. Ugbu a, o nwere ụdị teknụzụ ise dị mkpa: ikpo okwu teknụzụ nha ọbara rheology, ikpo okwu teknụzụ nnwale coagulation ọbara, ikpo okwu teknụzụ ihe ndị dị ndụ, teknụzụ isi nke ihe nchọpụta coagulation, na ụzọ traceability.
Ihe dị mkpa
Uru
Imeziwanye teknụzụ nha na ọkwa akpaaka nke ndị na-anwale coagulation na ndị na-anwale rheology ọbara dị ugbu a;
(2) Ahịrị R&D Coagulation, ihe nnwale ọbara akpaka na-agba ọsọ ọsọ, ihe nnwale ọbara akpaka na-agba ọsọ ọsọ, ihe nyocha ọrụ platelet na chaatị thromboelasticity na usoro ngwaahịa ndị ọzọ;
(3) Mee ka mmepụta ihe ndị dị mkpa dị n'elu onwe ha, dabere na ikpo okwu teknụzụ ihe ndị dị ndụ, Meziwanye mma na arụmọrụ nke ngwaahịa reagent;
(4) Mepụta vWF, LA, PC, PS, Anti-Xa, diluted thrombin time measurement (dTT), blood coagulation factor VIII na blood coagulation factor IX na ihe ndị ọzọ na-eme nchọpụta in vitro na njikwa mma ngwaahịa na ngwaahịa ọkọlọtọ na-emezu mkpa ahụike maka nchọpụta na nlekota nke thrombus, antiphospholipid syndrome, hemophilia na ọrịa ndị ọzọ, ma nọgide na-enwe uru ọkachamara Succeeder n'ọhịa nke nchọpụta in vitro nke thrombosis na hemostasis.
Asambodo
Kaadị azụmaahịa
WeChat nke Chaịna